Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and ph, and orocecal and colonic transit: Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers-Reference-Cited by-同舟云学术

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and ph, and orocecal and colonic transit: Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers

Published:2006-04 Issue:4 Volume:28 Page:569-581
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Houghton Lesley A.,Atkinson Wendy,Whorwell Peter J.,Morris Julie,Murdoch Robert D.,Cooper Stephen M.,Webber Dawn M.,Walls Christine M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference50 articles.

1. Anti inflammatory effects of the Phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease;Gamble;Am J Respir Crit Care Med,2003

2. Effect of cilomilast (Ariflo) on TNF-alpha, IL 8, and GM-CSF release by airway cells of patients with COPD;Profita;Thorax,2003

3. Rolipram versus imipramine in inpatients with major, “minor” or atypical depressive disorder: A double-blind double-dummy study-aimed at testing a novel therapeutic approach;Bertolino;Int Clin Psychopharmacol,1988

4. Phosphodiesterase type IV inhibitors;Palfreyman;Prog Med Chem,1996

5. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease;Spina;Drugs,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitroandin vivometabolism of CHF 6001, a selective phosphodiesterase (PDE4) inhibitor;Xenobiotica;2015-03-03

2. Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review;Current Pharmaceutical Design;2010-11-01

3. Acoustic Cough—Reflux Associations in Chronic Cough: Potential Triggers and Mechanisms;Gastroenterology;2010-09